This tender seeks suppliers for the provision and delivery of contraceptives and hormone modulating agents to the Department of Health from October 2026 to September 2029, ensuring access to essential health products.
The Department of Health is inviting tenders for the supply and delivery of contraceptives and hormone modulating agents for a three-year period, commencing on October 1, 2026, and concluding on September 30, 2029. This initiative aims to enhance reproductive health services across the country by ensuring a consistent and reliable supply of essential medical products. Suppliers are expected to meet stringent quality and regulatory standards, ensuring that all products are safe, effective, and compliant with health regulations.
Bidders must demonstrate their capacity to deliver these products efficiently and within the specified timelines. The tender includes detailed requirements regarding product specifications, packaging, labeling, and delivery logistics. Additionally, suppliers will be required to provide comprehensive documentation, including invoices and compliance certificates. This tender presents an opportunity for businesses in the pharmaceutical and medical supply sectors to contribute to public health initiatives while establishing a long-term partnership with the Department of Health.
This tender is suitable for pharmaceutical companies, medical supply distributors, and manufacturers specializing in contraceptives and hormone modulating agents. Businesses with experience in government contracts and a proven track record in delivering medical supplies are encouraged to apply.
•••••• •••• ••••••• ••••• •••••• •••••• •••••• ••••.
Get full access to this tender, including documents, location, and contact details.